RBFOX2 Recognizes N⁶-Methyladenosine to Suppress Transcription and Block Myeloid Leukaemia Differentiation

Scientists presented a pathway of m6A methyltransferase complex recruitment and m6A deposition on chromatin-associated RNAs, resulting in locus-selective chromatin regulation, which has potential therapeutic implications in leukemia.